Jiangsu Hengrui Medicine Revenue

Jiangsu Hengrui Medicine had revenue of 6.59B CNY in the quarter ending September 30, 2024, with 12.72% growth. This brings the company's revenue in the last twelve months to 26.00B, up 16.34% year-over-year. In the year 2023, Jiangsu Hengrui Medicine had annual revenue of 22.82B with 7.26% growth.

Revenue (ttm)

26.00B

Revenue Growth

+16.34%

P/S Ratio

10.81

Revenue / Employee

1.33M

Employees

19,611

Market Cap

282.07B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	22.82B	1.54B	7.26%
Dec 31, 2022	21.28B	-4.63B	-17.87%
Dec 31, 2021	25.91B	-1.83B	-6.59%
Dec 31, 2020	27.73B	4.45B	19.09%
Dec 31, 2019	23.29B	5.87B	33.70%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	38.50B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Shanghai United Imaging Healthcare	10.93B
Yunnan Baiyao Group Co.,Ltd	39.34B
Beijing Wantai Biological Pharmacy Enterprise	2.49B
Sichuan Biokin Pharmaceutical Co.,Ltd.	5.85B

Revenue Rankings